D03.7 - Melanoma in situ of lower limb, including hip

Version 2023
ICD-10:D03.7
Short Description:Melanoma in situ of lower limb, including hip
Long Description:Melanoma in situ of lower limb, including hip
Status: Not Valid for Submission
Version:ICD-10-CM 2023
Code Classification:

D03.7 is a non-specific and non-billable ICD-10 code code, consider using a code with a higher level of specificity for a diagnosis of melanoma in situ of lower limb, including hip. The code is not specific and is NOT valid for the year 2023 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding for Melanoma in situ of lower limb, including hip

Non-specific codes like D03.7 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for melanoma in situ of lower limb, including hip:

  • BILLABLE CODE - Use D03.70 for Melanoma in situ of unspecified lower limb, including hip
  • BILLABLE CODE - Use D03.71 for Melanoma in situ of right lower limb, including hip
  • BILLABLE CODE - Use D03.72 for Melanoma in situ of left lower limb, including hip

Index to Diseases and Injuries References

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:

Patient Education


Melanoma

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking."

Thinking of "ABCDE" can help you remember what to watch for:

Surgery is the first treatment of all stages of melanoma. Other treatments include chemotherapy and radiation, biologic, and targeted therapies. Biologic therapy boosts your body's own ability to fight cancer. Targeted therapy uses substances that attack cancer cells without harming normal cells.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Melanoma Summary

Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Skin Cancer (Including Melanoma)-Patient Version

Learn about melanoma risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History